Deadline: 28-May-25
The American Cancer Society (ACS) and Pfizer are collaborating to offer a new competitive grant opportunity focused on improving cancer care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) individuals in cancer treatment.
Area of Interest
- The intent of this grants program is to support quality improvement projects that reduce cancer treatment disparities and strengthen collaborations to improve cancer care for AIAN and NHPI individuals facing cancer.
- The proposed plan should include an assessment of barriers to equitable care developed in partnership with the AIAN and/or NHPI community during the planning phase. Partnership with the AIAN and/or NHPI community is required throughout project implementation (e.g. advisory committee, patient focus groups, coordination of care, educational initiatives that target health behavior change).
- The project timeline includes a planning phase for health system grantees to engage community-based organization (CBO) partners prior to beginning implementation. It is expected that grantees budget for the provision of grant dollars to CBO partners for their support of this effort ($ amount to be determined by the grantee).
- It is expected that projects are built on the foundation of an evidencebased approach, and the proposed evaluation plan will follow generally accepted scientific principles. During review, the intended outcome(s) of the project will be given careful consideration and projects with the maximum likelihood to directly impact patient care for AIAN and/or NHPI oncology patients across multiple cancer types and those that are sustainable post quality improvement project, scalable or replicable will be given highest priority.
- The intent of the collaboration is to support proposals focused on aspects related to cancer treatment. Proposals are asked to address cultural and geographic barriers to the delivery of standard of care (SOC) treatment. Additional barriers may also be addressed.
Funding Information
- The total available budget related to this RFP is approximately $1,500,000.
- Individual projects requesting up to a total of $250,000 to include both direct and indirect costs for the two-year project period will be considered. It is expected that community-based organizational partners receive funding to support this project.
Target Audience
- American Indian and Alaska Native (AIAN) and/or Native Hawaiian and Other Pacific Islander (NHPI) patients and communities
- Members of the health care team and administrators involved in the care of cancer patients
Geographic Scope
- United States (interventions for tribes that cross into Canada or Mexico are in scope)
Eligibility Criteria
- US health care institutions, large and small, providing oncology services to AIAN and/or NHPI patients.
- Tribal clinics providing oncology services and contracting with cancer centers for some services are eligible to apply.
- All applicants should already have established collaborations with AIAN and/or NHPI community-based organizations.
- If any component of a proposed project includes activities certified for CME/CE credit, the accredited organization providing the credit must be the requesting organization on the grant.
For more information, visit Pfizer.
